Nanoparticle Functionalization with Platelet Membrane Enables Multifactored Biological Targeting and Detection of Atherosclerosis

Abstract

Cardiovascular disease represents one of the major causes of death across the global population. Atherosclerosis, one of its most common drivers, is characterized by the gradual buildup of arterial plaque over time, which can ultimately lead to life-threatening conditions. Given the impact of the disease on public health, there is a great need for effective and noninvasive imaging modalities that can provide valuable information on its biological underpinnings during development. Here, we leverage the role of platelets in atherogenesis to design nanocarriers capable of targeting multiple biological elements relevant to plaque development. Biomimetic nanoparticles are prepared by coating platelet membrane around a synthetic nanoparticulate core, the product of which is capable of interacting with activated endothelium, foam cells, and collagen. The effects are shown to be exclusive to platelet membrane-coated nanoparticles. These biomimetic nanocarriers are not only capable of efficiently localizing to well-developed atherosclerotic plaque, but can also target subclinical regions of arteries susceptible to plaque formation. Using a commonly employed magnetic resonance imaging contrast agent, live detection is demonstrated using an animal model of atherosclerosis. Ultimately, this strategy may be leveraged to better assess the development of atherosclerosis, offering additional information to help clinicians better manage the disease.

PEGylated tumor cell membrane vesicles as a new vaccine platform for cancer immunotherapy

“…Exploiting the recent advances in plasma membrane-based drug delivery approaches, including vaccines [22–26], we formulated tumor cell membranes into monodisperse nanoparticles coated with a surface layer of polyethylene glycol (PEG-NPs) (Fig. 1).…”

Engineering Cell Membrane‐Based Nanotherapeutics to Target Inflammation

“…Recently, noninvasive cell therapy applying ischemic tissue-directed homing response has generated positive results. [109] Nanoparticles with enriched CXCR4 receptor (BSMNCs) showed better accumulation in ischemic tissue. As summarized in Table 1, inflammation-directed migration of MSCs is mediated by CXCR4 on the plasma surface.…”

Nanotechnology‐Mediated Drug Delivery for the Treatment of Obesity and Its Related Comorbidities

“…Furthermore, it was found that fabricated PNPs showed an impressive ability to bind different components of atherosclerotic plaques in vitro. These PNPs also showed an ability to bind not only areas with serious plaque formation, but correspondingly areas that display light plaque formation and preatherosclerotic areas . The nanoparticle formulations described above are promising solutions for treating cardiovascular diseases, especially the targeted treatment of atherosclerotic diseases utilizing the natural atherosclerotic plaque‐targeting abilities of HDL and platelet membranes, and all speak to the great ingenuity of NP therapies which are under development.…”